Histogen, Inc. (HSTO)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research

Current Price

as of Feb 07, 2025

$0.03

P/E Ratio

N/A

Market Cap

$122.39K

Description
Add to research

Histogen, Inc. engages in the development of potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. It focuses on Human Multipotent Cell Conditioned Media, Human Extracellular Matrix, and Hair Stimulating Complex. The company was founded by Steven J. Mento and Gail K. Naughton on July 13, 2005 and is headquartered in San Diego, CA.

Metrics
Add to research

Overview

  • HQSan Diego, CA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerHSTO
  • Price$0.02870.00%

Trading Information

  • Market cap$0.12M
  • Float97.24%
  • Average Daily Volume (1m)306
  • Average Daily Volume (3m)1,271
  • EPS-$2.90

Company

  • Revenue$0.02M
  • Rev growth (1yr)265.21%
  • Net incomeN/A
  • Gross marginN/A
  • EBITDA margin-278.67%
  • EBITDAN/A
  • EVN/A
  • EV/Revenue-1.66
  • P/EN/A
  • P/S6.44
  • P/B0.02
  • Debt/Equity32.15
Documents
Add to research